DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Saini SS. et al.
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.
The Journal of investigative dermatology 2015;
135 (01) 67-75
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.